|
Feb 21
|
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
|
|
Feb 20
|
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
|
|
Feb 19
|
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
|
|
Feb 15
|
Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024)
|
|
Feb 13
|
Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
|
|
Feb 11
|
Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy
|
|
Feb 10
|
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
|
|
Oct 9
|
Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution
|
|
Oct 1
|
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services
|
|
Sep 27
|
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
|
|
Jul 24
|
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
|
|
Jun 20
|
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
|
|
Jun 19
|
When Will Intelligent Bio Solutions Inc. (NASDAQ:INBS) Become Profitable?
|
|
Jun 19
|
Intelligent Bio begins dosing for non-invasive drug screening technology
|
|
Jun 18
|
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
|
|
Mar 1
|
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
|
|
Feb 28
|
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
|
|
Dec 19
|
Intelligent Bio Solutions Receives NATA Accreditation for its Revolutionary Fingerprint Sweat Drug Screening System
|
|
Dec 6
|
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
|
|
Dec 5
|
Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
|